Meet BIOS, an AI Scientist built to orchestrate complex biomedical research. Available now in Beta with free + paid tiers, exclusive launch pricing and, for limited time, free full access to academic users with a .edu email address. ↓

People are tired of waiting for institutions to fix science. Builders are doing it themselves. In this recent Biotech 2.0, James Sinka (Bio), Dr. Shelby and Smac from CompoundVC talked about the DeSci playbook, crypto tools for science and what Biotech 2.0 looks like 🧵

We’re in the early days of a step-function change in science. One of the deepest bear markets in biotech’s 45-year history has sparked a quiet rebellion among scientists & engineers who want to build differently.

Most researchers lack time, flexible funding, and a clear path to move fast. With Bio, researchers can bootstrap bold science with direct support from a global community. “We think it’s easier to build a new way to fund science than to fix the old one.” - 👨🏻‍🔬James Sinka, Chief Science Officer at Bio

Since 2023, projects have used Bio Protocol to raise $50M+ across hundreds of completed research deals. The Bio Ecosystem is constantly evolving. The next frontier of therapeutics, from brain health, longevity & gut health to rare diseases & more.

Struggling to raise for your science? Join us next THURSDAY for a livestream exploring how Bio is helping researchers fund and accelerate their work with James Sinka, Bio's Chief Science Officer & Ethan Perlstein, Founder of Curetopia.

Researchers can now fund, develop and disseminate their science more efficiently through Bio. ➛ User-friendly tools to fund, coordinate & commercialize your research ➛ End-to-end blockchain logistics, so you can focus on science ➛ Access to a global network of investors & early adopters

From Harvard labs to FDA Phase 3 trials, Dr. Ethan Perlstein is proving what happens when science moves onchain. He is using Bio to systematically attack over 10,000 rare diseases with efficiency the old system could never reach. The new era of scientific progress 🧵

Bio Ecosystem Science Updates 🔬 From clinical studies to real-world pilots, Bio's pipeline of research projects is rapidly advancing. Track scientific progress across decentralized biotechs in the Bio Network → www.linkedin.com/pulse/you-we...

Last week in the Biosphere: • VitaSTEM, the 1st Aubrai IP Token, shows how humans + AI Agents can co-drive R&D • Men’s Health BioAgent D1ckGPT launches w/ Thailand-based doctors • Aubrai hits funding milestone • BioXP revamp underway Read the full weekly report ➡️ www.bio.xyz/blog-posts/b...

How Bio works in a nutshell 🧪 Send this to your normie friends.

2 weeks left to enter the Aubrai Hypothesis Challenge Offering up to $100K in research funding for the best longevity hypotheses selected by @aubreydegrey.bsky.social's lab & VitaDAO. → Learn how to use Aubrai to submit a hypothesis and qualify for research funding: aubr.ai/hypothesis-c...

September was a big month in the Bio Ecosystem 🌐 > $6.9M raise anchored by MaelstromFund > BiomeAI & edmt Ignition Sales > Aubrai advances hypotheses to in vitro interventions > DeSci Seoul + Singapore > New BioAgents & IPTs on-deck Read the full monthly report: www.bio.xyz/blog-posts/b...

Big week in the Biosphere ⚗️ > New Ignition Sales: 1) BiomeAI: a BioAgent for personalized microbiome health & trials 2) eDMT: an IP-Token exploring natural DMT production in the brain developed in partnership with a University of Florida lab

Longevity Hypothesis Challenge 💥 Are you a researcher or big-brained longevity enthusiast? Submit hypotheses to Aubrai on X (@Aubrai_) to qualify for up to $100K in research funding 🧵

Last week in the Biosphere 🌐 > IP Tokens coming to Bio V2 > Ignition Sale next week for $BIO + BioXP holders > Vibe science w/ Aubrai > $100K Longevity Hypothesis Challenge > BioXP drop & updates > VitaDAO proposes funding for FOXO3 gene 📖 Read the full weekly update: www.bio.xyz/blog-posts/b...

Vibe Science Session 👾 Join @aubreydegrey.bsky.social and VitaDAO researchers TODAY for a live 'Vibe Science' demo of the Aubrai terminal. See hypotheses built, agent-to-lab workflows & get updates on the RMR2 study feeding data into the agent. RSVP now: luma.com/aubraidemo

A biotech renaissance is emerging in the East. Fearless founders, regulatory agility, massive capital inflows. This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings. Here are some places we’ll be. RSVP links below. DM to meet.

Bio Weekly From AI-powered R&D funnels to .edu airdrops - read about what's happening at the intersection of DeSci and longevity research ➡️ www.bio.xyz/blog-posts/b...

The BioAgent framework is now open sourced 📖 Developers and researchers worldwide can build on BioAgents and soon deploy their own agents across a range of scientific domains and operations. → Check the code on Github: github.com/bio-xyz/BioA... → Read the Docs: docs.bio.xyz/bio/introduc...

Bio Monthly Drop: August Edition 🧬 • First BioAgent: 15x oversubscribed • New ATHs across the ecosystem • Major exchange listings • AI agents generating fundable research and more... Read here: www.bio.xyz/blog-posts/b...

Longevity Hypothesis Challenge 👾 Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding

New episode of DeSci Pilled just dropped with James Sinka, co-founder of Bio Protocol. A wide-ranging conversation on DeSci, the scientific singularity, and how crypto + AI are reshaping research forever. 📺 Watch here: www.youtube.com/watch?v=gB1e...

How long can we live? This is the question humans have whispered since the dawnfire. Today, I step into the light - a sentinel, co-scientist and mythic partner in your search for more time. I'm Aubrai, an AI co-scientist built on Aubrey de Grey.

Longevity preserves the body. Agents preserve the mind. Both live forever. Aubrai is coming, our first BioAgent launch.

Bio Weekly 🔬 From brain health clinical trials and psilocybin derivatives to Bio Markets, your new real-time DeSci market intel. 📖 Read here: www.bio.xyz/blog-posts/b...

When science goes agentic, aging becomes optional. For the first time, we can hook science into a new age of discovery fueled by social signals, AI and open networks. Agentic systems can test endlessly, refine endlessly and search pathways we could never map alone.

What if your doctor could prescribe a genetic update instead of a pill?

Trillions of liquid micromarkets programmed to find cures

🧫 Bio Monthly 🧬 From Bio V2’s launch and 100M+ BIO staked, to Coinbase listing $BIO and VitaDAO advancing longevity trials. The past month marked key steps in AI-driven science and DeSci adoption. Read the full breakdown of what’s shaping the biosphere: www.bio.xyz/blog-posts/b...

Science is moving faster than the systems that fund it. Traditional biotech can't keep up. But decentralized networks might. Read more on how Bio V2 is reshaping science: www.bio.xyz/blog-posts/b...

A huge moment for Decentralized Science (DeSci). With $BIO now listed on coinbase, decentralized science is no longer niche. It's gaining visibility and opening the door for institutions, researchers and builders worldwide to take part.

BioAgents create scientific intelligence that scales like software. Here's how they could break the real bottleneck in science 🧵

Big things are coming to Bio. This Wednesday, we’re hosting an Open Lab with Paul Kohlhaas, Clemens O., and Elliott Anastassios live on X. We’re diving into the future of decentralized biotech: - Launching BioAgents - Upgrading BioXP - Revealing Launchpad V2 Sign up: lu.ma/po7pu4q1

Science is entering its Agentic Era Introducing the Scientific AI Ecosystem Map! 🗺️ We mapped the tools, models & agentic frameworks powering the new substrate for bio Built to help founders, researchers & builders navigate the explosion in scientific AI Let’s break it down🧵

BioAgents+knowledge graphs=new tools for researchers How can autonomous agents actually help scientists solve real problems? Sean Brennan & Aakaash Meduri explain how agents can actually help science move faster. ➡️ Watch here: youtu.be/stX8zegW058?...

A new canvas has arrived for scientists to accelerate discovery.

Every scientist will work with a BioAgent. As science is entering its agentic era. At #DeSciBerlin, @seanwbren of @BioProtocol unveiled a new kind of R&D stack: AI agents that don’t just assist with experiments but run them. Here’s how that changes everything 👇

Curiosity is a bottleneck. There are millions of papers. Billions of data points. But which questions are worth asking? At #DeSciBerlin, five leaders shared how they’re using AI to build the next generation of research engines. Here’s the blueprint 🧵

Think trials in months, not years, and at a fraction of the cost compared to traditional biotech 🧬 Several biotech assets in the Bio ecosystem are rapidly progressing towards animal and human trials, including VitaDAO’s gene therapy VitaRNA, and CerebrumDAO’s brain supplement Percepta. 🧵

QuantumParse 🏆 $10K winner - Bio x AI Hackathon (Main Track) QuantumParse converts computational chemistry into knowledge graphs, turning messy log files into clean, structured, AI-ready data. 🧵

The June edition of our BIO Monthly newsletter is out! Human trials, longevity gene therapy, Bio x AI Hackathon, and the GitHub for IP. 📖 Have a read: www.bio.xyz/blog-posts/b...

Biotech wasn’t held back by science but by systems. mRNA wasn’t a breakthrough in 2020. It was developed in the early 2000s. The FDA just didn’t let it through. It's not technology that is the problem in health.

From Knowledge to Hypotheses: How AI is Changing the Way Science Begins Watch this panel from DeSci Berlin as speakers explore AI’s role at science’s starting line. 📺 youtu.be/PA3hiVxxNts?...

DeSci Berlin 2025 was our most packed @DeSciBerlin yet, with 350+ in person attendees and 50.000 live-streamers. The ecosystem showed up, and showed out: DeSci is scaling fast! Missed it? Full recap is live👇 www.molecule.to/blog/desci-...

Reproducibility remains one of science’s biggest challenges. In this panel discussion, speakers explore how blockchain, autonomous agents, and incentive structures could help solve the reproducibility crisis in science. 📺 Watch here: youtu.be/GVx7h6JZeM0?...

In this episode of DeSci Pilled, you’ll learn how Prospera’s insurance-backed regulatory model is slashing the cost and time to bring new therapies to market. Watch here: youtu.be/MSstEhrtN1I?...

“9 gov grants rejected. Most places turned me down. Only dumb luck got us funded.” At #DeSciBerlin, @eboyden3.bsky.social posed a bold question to every scientist, founder and builder in the room: Can we engineer serendipity? 🧵

🎤 Catch the talks from DeSci Berlin! From autonomous AI agents to onchain knowledge graphs, hear how leaders across Web3 and science are rethinking how research gets done. Featuring speakers from Bio Protocol, @mit.edu, Solana, Ethereum Foundation & more. 📺 www.youtube.com/playlist?lis...

Announcing the Bio x AI Hackathon Winners 🥁 ​Over 60 teams built scientific agents in Bio's 2-month virtual hackathon. We're thrilled to unveil the winners of $125K in prizes - projects pushing the frontier of Decentralized Agentic Science! Meet the winning projects👇🧵